|
Transforming growth factor beta and the bleb scarring after glaucoma filtration surgery
ZHANG Jia-ying, XIAO Yi-qin, YE Wen.
International Review of Ophthalmology
2012, 36 (2):
116-121.
DOI: 10. 3760/ cma. j. issn16735803. 2012. 02. 009
Bleb scarring is the main cause of glaucoma filtration surgery failure. Transforming growth factorbeta (TGFβ) can induce the phenotypic modulation of human Tenon's capsule fibroblasts, then cause further migration, proliferation of the cells, synthesis of extracellular matrix, and eventually lead to the scarring of the bleb. There had been a lot of researchs at cytokine and gene level in antifibrotic area in recent years, which include TGFβ antibodies (such as antiTGFβ2 antibody, CAT152), TGFβ inhibitors (such as decorin, chymase inhibitor, SB431542, etc.) and genetic level reagents (such as TGFβ antisense oligonucleotides, etc.) to inhibit the important target and protein expression in TGFβ signaling pathways (such as ALK5/Smad2/Smad3, MAPK, RhoROCK, PI3KAKT signaling pathways, etc.), so as to achieve the role of reducing bleb scarring. But most of these drugs were lack of clinical trials support and of comparative studies among different drugs. Therefore, indepth studies are still needed to explore the relationship among TGFβ cell signaling pathways, and find the best target for the regulation of bleb scarring. (Int Rev Ophthalmol, 2012, 36: 116121)
Related Articles |
Metrics
|
|